Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Margreet G. Franken; Brenda Leeneman; Anouk Jochems; Maartje G. Schouwenburg; Maureen J. B. Aarts; Alexander C. J. van Akkooi; Franchette W. P. . J. van den Berkmortel; Alfonsus J. M. van den Eertwegh; Jan Willem B. de Groot; Koos J. M. van der Hoeven; Geke A. P. Hospers; Ellen Kapiteijn; Rutger Koornstra; Wim H. J. Kruit; Marieke W. J. Louwman; Djura Piersma; Rozemarijn S. van Rijn; Karijn P. M. Suijkerbuijk; Albert J. ten Tije; Gerard Vreugdenhil; Michel W. J. M. Wouters; Michiel van Zeijl; John B. A. G. Haanen; Carin A. Uyl-de Groot

doi:10.1097/CAD.0000000000000628

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Margreet G. Franken, Brenda Leeneman, Anouk Jochems, Maartje G. Schouwenburg, Maureen J. B. Aarts, Alexander C. J. van Akkooi, Franchette W. P. . J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Koos J. M. van der Hoeven, Geke A. P. Hospers, Ellen Kapiteijn, Rutger Koornstra, Wim H. J. Kruit, Marieke W. J. Louwman, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J. ten Tije, Gerard VreugdenhilMichel W. J. M. Wouters, Michiel van Zeijl, John B. A. G. Haanen, Carin A. Uyl-de Groot

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	579-588
Number of pages	10
Journal	Anti-Cancer Drugs
Volume	29
Issue number	6
DOIs	https://doi.org/10.1097/CAD.0000000000000628
Publication status	Published - 1 Jul 2018

Keywords

advanced cutaneous melanoma
colitis
healthcare costs
immune-related adverse events
ipilimumab
CLINICAL-PRACTICE GUIDELINES
METASTATIC MELANOMA
ECONOMIC BURDEN
FOLLOW-UP
DACARBAZINE
DIAGNOSIS
TOXICITY
FRANCE
TRIALS

Access to Document

10.1097/CAD.0000000000000628

Cite this

Franken, M. G., Leeneman, B., Jochems, A., Schouwenburg, M. G., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. . J., van den Eertwegh, A. J. M., de Groot, J. W. B., van der Hoeven, K. J. M., Hospers, G. A. P., Kapiteijn, E., Koornstra, R., Kruit, W. H. J., Louwman, M. W. J., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., ... Uyl-de Groot, C. A. (2018). Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. Anti-Cancer Drugs, 29(6), 579-588. https://doi.org/10.1097/CAD.0000000000000628

Franken, Margreet G. ; Leeneman, Brenda ; Jochems, Anouk ; Schouwenburg, Maartje G. ; Aarts, Maureen J. B. ; van Akkooi, Alexander C. J. ; van den Berkmortel, Franchette W. P. . J. ; van den Eertwegh, Alfonsus J. M. ; de Groot, Jan Willem B. ; van der Hoeven, Koos J. M. ; Hospers, Geke A. P. ; Kapiteijn, Ellen ; Koornstra, Rutger ; Kruit, Wim H. J. ; Louwman, Marieke W. J. ; Piersma, Djura ; van Rijn, Rozemarijn S. ; Suijkerbuijk, Karijn P. M. ; ten Tije, Albert J. ; Vreugdenhil, Gerard ; Wouters, Michel W. J. M. ; van Zeijl, Michiel ; Haanen, John B. A. G. ; Uyl-de Groot, Carin A. / Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. In: Anti-Cancer Drugs. 2018 ; Vol. 29, No. 6. pp. 579-588.

@article{901007183c2d425ca276bb8846ea7ec2,

title = "Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands",

keywords = "advanced cutaneous melanoma, colitis, healthcare costs, immune-related adverse events, ipilimumab, CLINICAL-PRACTICE GUIDELINES, METASTATIC MELANOMA, ECONOMIC BURDEN, FOLLOW-UP, DACARBAZINE, DIAGNOSIS, TOXICITY, FRANCE, TRIALS",

author = "Franken, {Margreet G.} and Brenda Leeneman and Anouk Jochems and Schouwenburg, {Maartje G.} and Aarts, {Maureen J. B.} and {van Akkooi}, {Alexander C. J.} and {van den Berkmortel}, {Franchette W. P. . J.} and {van den Eertwegh}, {Alfonsus J. M.} and {de Groot}, {Jan Willem B.} and {van der Hoeven}, {Koos J. M.} and Hospers, {Geke A. P.} and Ellen Kapiteijn and Rutger Koornstra and Kruit, {Wim H. J.} and Louwman, {Marieke W. J.} and Djura Piersma and {van Rijn}, {Rozemarijn S.} and Suijkerbuijk, {Karijn P. M.} and {ten Tije}, {Albert J.} and Gerard Vreugdenhil and Wouters, {Michel W. J. M.} and {van Zeijl}, Michiel and Haanen, {John B. A. G.} and {Uyl-de Groot}, {Carin A.}",

year = "2018",

month = jul,

day = "1",

doi = "10.1097/CAD.0000000000000628",

language = "English",

volume = "29",

pages = "579--588",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "6",

}

Franken, MG, Leeneman, B, Jochems, A, Schouwenburg, MG, Aarts, MJB, van Akkooi, ACJ, van den Berkmortel, FWPJ, van den Eertwegh, AJM, de Groot, JWB, van der Hoeven, KJM, Hospers, GAP, Kapiteijn, E, Koornstra, R, Kruit, WHJ, Louwman, MWJ, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, van Zeijl, M, Haanen, JBAG & Uyl-de Groot, CA 2018, 'Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands', Anti-Cancer Drugs, vol. 29, no. 6, pp. 579-588. https://doi.org/10.1097/CAD.0000000000000628

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. / Franken, Margreet G.; Leeneman, Brenda; Jochems, Anouk; Schouwenburg, Maartje G.; Aarts, Maureen J. B.; van Akkooi, Alexander C. J.; van den Berkmortel, Franchette W. P. . J.; van den Eertwegh, Alfonsus J. M.; de Groot, Jan Willem B.; van der Hoeven, Koos J. M.; Hospers, Geke A. P.; Kapiteijn, Ellen; Koornstra, Rutger; Kruit, Wim H. J.; Louwman, Marieke W. J.; Piersma, Djura; van Rijn, Rozemarijn S.; Suijkerbuijk, Karijn P. M.; ten Tije, Albert J.; Vreugdenhil, Gerard; Wouters, Michel W. J. M.; van Zeijl, Michiel; Haanen, John B. A. G.; Uyl-de Groot, Carin A.

In: Anti-Cancer Drugs, Vol. 29, No. 6, 01.07.2018, p. 579-588.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

AU - Franken, Margreet G.

AU - Leeneman, Brenda

AU - Jochems, Anouk

AU - Schouwenburg, Maartje G.

AU - Aarts, Maureen J. B.

AU - van Akkooi, Alexander C. J.

AU - van den Berkmortel, Franchette W. P. . J.

AU - van den Eertwegh, Alfonsus J. M.

AU - de Groot, Jan Willem B.

AU - van der Hoeven, Koos J. M.

AU - Hospers, Geke A. P.

AU - Kapiteijn, Ellen

AU - Koornstra, Rutger

AU - Kruit, Wim H. J.

AU - Louwman, Marieke W. J.

AU - Piersma, Djura

AU - van Rijn, Rozemarijn S.

AU - Suijkerbuijk, Karijn P. M.

AU - ten Tije, Albert J.

AU - Vreugdenhil, Gerard

AU - Wouters, Michel W. J. M.

AU - van Zeijl, Michiel

AU - Haanen, John B. A. G.

AU - Uyl-de Groot, Carin A.

PY - 2018/7/1

Y1 - 2018/7/1

KW - advanced cutaneous melanoma

KW - colitis

KW - healthcare costs

KW - immune-related adverse events

KW - ipilimumab

KW - CLINICAL-PRACTICE GUIDELINES

KW - METASTATIC MELANOMA

KW - ECONOMIC BURDEN

KW - FOLLOW-UP

KW - DACARBAZINE

KW - DIAGNOSIS

KW - TOXICITY

KW - FRANCE

KW - TRIALS

U2 - 10.1097/CAD.0000000000000628

DO - 10.1097/CAD.0000000000000628

M3 - Article

VL - 29

SP - 579

EP - 588

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 6

ER -